Related Experiment Video
Updated: Jan 6, 2026
09:33
An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins
Published on: June 26, 2018
7.9K
Neuromodulator Signaling Bidirectionally Controls Vesicle Numbers in Human Synapses
Christopher Patzke1, Marisa M Brockmann2, Jinye Dai3
1Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA.
Cell
|October 5, 2019
Summary
Researchers found that neuromodulators control synaptic vesicle numbers in human neurons by regulating synapsin-1 phosphorylation. This mechanism impacts neurotransmitter release and synaptic communication.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Neuromodulators act on G protein-coupled receptors (GPCRs) to alter intracellular cyclic AMP (cAMP) and Ca2+ levels.
- These processes are crucial for brain function and implicated in neurological disorders.
Purpose of the Study:
- To uncover novel presynaptic mechanisms regulating synaptic communication in human neurons.
- To elucidate the role of neuromodulators in controlling synaptic vesicle dynamics.
Main Methods:
- Investigated neuromodulator receptor activation in human neurons.
- Measured changes in synaptic vesicle numbers and synapsin-1 phosphorylation.
- Utilized conditional deletion of synapsin-1 to assess its role.
Main Results:
- Neuromodulator receptor activation bidirectionally controlled synaptic vesicle numbers.
- Synaptic vesicle regulation correlated with cAMP-dependent protein kinase A (PKA)-mediated synapsin-1 phosphorylation.
- Neuromodulator-induced control of vesicle numbers was largely dependent on synapsin-1.
Conclusions:
- A novel presynaptic mechanism involving synapsin-1 regulates synaptic vesicle numbers and neurotransmitter release.
- Non-phosphorylated synapsin-1 latches vesicles, while phosphorylation releases them, demonstrating bidirectional control.
- Synapsin-1 acts as a key effector of neuromodulator signaling in human neurons.
Related Concept Videos
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
785
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
785
01:12Synaptic Signaling
79.0K
Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
79.0K
01:09Synaptic Signaling
6.5K
Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
Most synapses are chemical, meaning an electrical impulse or action potential spurs the release of chemical messengers called neurotransmitters. The neuron sending the signal is called the presynaptic neuron, and the neuron receiving the signal is the postsynaptic neuron.
The presynaptic neuron fires an action potential that...
Most synapses are chemical, meaning an electrical impulse or action potential spurs the release of chemical messengers called neurotransmitters. The neuron sending the signal is called the presynaptic neuron, and the neuron receiving the signal is the postsynaptic neuron.
The presynaptic neuron fires an action potential that...
6.5K
01:26Fusion of Secretory Vesicles with the Plasma Membrane
16.5K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
16.5K
01:29Excitatory and Inhibitory Effects of Neurotransmitters
12.4K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
12.4K
01:26Neurochemical Transmission: Sites of Drug Action
3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K